These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1755332)
1. Pharmacogenetically hazardous drugs: a proposed new scoring method. Szórády I; Sánta A Acta Physiol Hung; 1991; 77(3-4):305-18. PubMed ID: 1755332 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic polymorphism of drug metabolism. Paxton JW N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031 [No Abstract] [Full Text] [Related]
3. Polymorphic differences in drug metabolism and response. Vetticaden SJ Methods Find Exp Clin Pharmacol; 1988 Aug; 10(8):531-6. PubMed ID: 3067018 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetics of oxidation reactions of drugs]. Jacqz-Aigrain E Arch Fr Pediatr; 1989 Jan; 46(1):59-65. PubMed ID: 2653266 [TBL] [Abstract][Full Text] [Related]
5. [Stability and/or variability of the expression of genetic polymorphism of hydroxylation and acetylation in patients with various pathologies and under various treatments]. Bechtel P; Joanne C; Bechtel Y; Grandmottet M; Jounet JM Ann Biol Clin (Paris); 1986; 44(4):361-7. PubMed ID: 3538951 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and the concept of individualized medicine. Shastry BS Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022 [TBL] [Abstract][Full Text] [Related]
7. Genetic factors in drug metabolism. Belle DJ; Singh H Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835 [TBL] [Abstract][Full Text] [Related]
8. [Genetic causes for the variability of effects and side effects of drugs]. Roots I Internist (Berl); 1982 Nov; 23(11):601-9. PubMed ID: 6759450 [No Abstract] [Full Text] [Related]
9. Ethnic differences in reactions to drugs and xenobiotics. Therapy. Evans DA Prog Clin Biol Res; 1986; 214():491-526. PubMed ID: 3523517 [No Abstract] [Full Text] [Related]
10. Polymorphic drug oxidation in humans. Eichelbaum M Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436 [TBL] [Abstract][Full Text] [Related]
11. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF; Liu JP; Chowbay B Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967 [TBL] [Abstract][Full Text] [Related]
12. [Genetic polymorphism of acetylation and hydroxylation in the Briton population]. Bressollette L; Berthou F; Riche C; Mottier D; Floch HH Therapie; 1990; 45(2):99-103. PubMed ID: 2353336 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenomics: the quest for individualized therapy]. López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenetics of anticancer drugs]. de Chaisemartin L; Loriot MA Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic approaches to the prediction of drug response. Vesell ES NIDA Res Monogr; 1986; 66():25-40. PubMed ID: 3106816 [No Abstract] [Full Text] [Related]
17. Drug acetylator phenotypes in newborn infants. Szórády I; Sánta A; Veress I Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445 [TBL] [Abstract][Full Text] [Related]
18. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Spielberg SP Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of antipsychoatics. Ozaki N Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062 [TBL] [Abstract][Full Text] [Related]